Apolipoprotein E recycling implications for dyslipidemia and atherosclerosis

被引:107
|
作者
Heeren, J
Beisiegel, U
Grewal, T
机构
[1] Univ Hamburg, Hosp Eppendorf, Inst Biochem & Mol Biol 2, D-20246 Hamburg, Germany
[2] Univ New S Wales, St Vincents Hosp, Ctr Immunol, Sydney, NSW, Australia
关键词
apolipoprotein E; HDL; endocytosis; cholesterol efflux; triglyceride-rich lipoproteins;
D O I
10.1161/01.ATV.0000201282.64751.47
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
After receptor-mediated endocytosis, the intracellular fate of triglyceride-rich lipoproteins (TRLs) is far more complex than the classical degradation pathway of low-density lipoproteins. Once internalized, TRLs disintegrate in peripheral endosomes, followed by a differential sorting of TRL components. Although core lipids and apolipoprotein B are targeted to lysosomes, the majority of TRL-derived apolipoprotein E (apoE) remains in peripheral recycling endosomes. This pool of TRL-derived apoE is then mobilized by high-density lipoproteins (HDLs) or HDL-derived apoA-I to be recycled back to the plasma membrane, followed by apoE resecretion and the subsequent formation of apoE-containing HDL. The HDL-induced recycling of apoE is accompanied by cholesterol efflux and involves the internalization and targeting of HDL-derived apoA-I to endosomes containing both apoE and cholesterol. These findings point to a yet unknown intracellular link between TRL-derived apoE, cellular cholesterol transport, and HDL metabolism. Recent studies provide first evidence that impaired recycling of TRL-derived apoE4, but not apoE3, is associated with intracellular cholesterol accumulation, which might explain some well-documented effects of apoE4 on HDL metabolism. This review summarizes the current understanding of apoE recycling and its potential role in the regulation of plasma apoE levels in the postprandial state.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 50 条
  • [1] Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice
    Atkinson, Robin D.
    Coenen, Kimberly R.
    Plummer, Michelle R.
    Gruen, Marnie L.
    Hasty, Alyssa H.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (02): : E284 - E290
  • [2] Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis
    Kawakami, Akio
    Yoshida, Masayuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (01) : 6 - 11
  • [3] Apolipoprotein E and Atherosclerosis
    A. D. Marais
    Current Atherosclerosis Reports, 2021, 23
  • [4] Apolipoprotein E and atherosclerosis
    Curtiss, LK
    Boisvert, WA
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (03) : 243 - 251
  • [5] Apolipoprotein E and Atherosclerosis
    Marais, A. D.
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (07)
  • [6] The current state of apolipoprotein E in dyslipidemia
    Rasmussen, Katrine L.
    Frikke-Schmidt, Ruth
    CURRENT OPINION IN LIPIDOLOGY, 2024, 35 (02) : 78 - 84
  • [7] Deficiency in ataxia telangiectasia mutated gene aggregates atherosclerosis and dyslipidemia of apolipoprotein E knockout mice
    Yang, H
    Shi, MJ
    Guo, ZM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E19 - E19
  • [8] Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
    Johnson, Lance A.
    Arbones-Mainar, Jose M.
    Fox, Raymond G.
    Pendse, Avani A.
    Altenburg, Michael K.
    Kim, Hyung-Suk
    Maeda, Nobuyo
    DIABETES, 2011, 60 (09) : 2285 - 2294
  • [9] Recycling of apolipoprotein E in macrophages
    Hasty, AH
    Plummer, MR
    Linton, MF
    Fazio, S
    Swift, LL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E55 - E55
  • [10] Apolipoprotein E polymorphism and atherosclerosis
    Kolovou, G
    Daskalova, D
    Mikhailidis, DP
    ANGIOLOGY, 2003, 54 (01) : 59 - 71